RxDoctor Payments Data

Leonel Borjon, PA

Physician Assistant · North Las Vegas, NVNPI 1528418647

Payments from drug & device makers

$3,809in general payments, 2019–2025

Across 88 payments — averaging $43.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • AbbVie$728
  • Abbott$455
  • Medtronic$452
  • SPR Therapeutics, Inc$335
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$174
  • plus $538 from 12 others

What the payments were for

  • Food & beverage$3,809100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,809 in reported general payments places this provider in the 85th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$41,937
Medicare patients
139
Services billed
569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide20$52,596
LicartDiclofenac Epolamine39$27,935
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen493$18,197
OxycontinOxycodone Hcl46$15,607
Diclofenac Sodium77$15,131
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen474$13,425
MovantikNaloxegol Oxalate26$10,362
Pregabalin214$7,115
Diclofenac Epolamine12$7,096
Oxycodone Hcl331$6,754
LinzessLinaclotide12$6,172
Lidocaine86$5,449
Fentanyl24$3,132
Gabapentin324$2,853
Cyclobenzaprine Hcl126$1,648

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$174$52,59620 claims
IBSA Pharma Inc.Licart$139$27,93539 claims
Redhill Biopharma Inc.Movantik$43$10,36226 claims
AbbVieLinzess$728$6,17212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in North Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →